Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -337,708 | -341,973 | -290,509 | -363,872 | -52,412 |
| Depreciation Amortization | -6,851 | -5,494 | 5,312 | 5,977 | 3,133 |
| Accounts receivable | N/A | 306 | 97 | 74,677 | -75,000 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 930 | -410 |
| Other Working Capital | 14,620 | -32,458 | 11,246 | 97,344 | -85,170 |
| Other Operating Activity | 80,832 | 79,303 | 44,364 | 110,538 | 107,370 |
| Operating Cash Flow | $-249,107 | $-300,316 | $-229,490 | $-74,406 | $-102,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 611,564 | 647,302 | 355,736 | 529,923 | 350,058 |
| PPE Investments | -2,018 | -4,126 | -9,062 | -3,471 | -1,931 |
| Net Acquisitions | N/A | N/A | N/A | -25,298 | N/A |
| Purchase Of Investment | -650,629 | -385,542 | -535,419 | -980,665 | -266,455 |
| Investing Cash Flow | $-41,083 | $257,634 | $-188,745 | $-479,511 | $81,672 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 270,153 | 34,753 | 289,910 | 388,090 | 426,509 |
| Financing Cash Flow | $270,153 | $34,753 | $289,910 | $388,090 | $426,509 |
| Beginning Cash Position | 146,443 | 154,372 | 282,697 | 448,524 | 42,832 |
| End Cash Position | 126,406 | 146,443 | 154,372 | 282,697 | 448,524 |
| Net Cash Flow | $-20,037 | $-7,929 | $-128,325 | $-165,827 | $405,692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249,107 | -300,316 | -229,490 | -74,406 | -102,489 |
| Capital Expenditure | -2,018 | -4,126 | -9,062 | -3,471 | -1,931 |
| Free Cash Flow | -251,125 | -304,442 | -238,552 | -77,877 | -104,420 |